Content area
Abstract
(CCNMatthews - Aug. 25, 2005) - ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that results from an engineering optimization study conducted at the Cedars Breast Center of the Royal Victoria Hospital in Montreal, Quebec, Canada, under the supervision of Dr. David Fleiszer, have been published in the August issue of Academic Radiology. The article, entitled "Time-Domain Optical Mammography SoftScan(R): Initial Results", illustrates the sensitivity of near-infrared (NIR) optical techniques to the metabolic functions of breast tissue. Using the non-invasive SoftScan system, 49 women underwent tests resulting in statistically significant discrimination of malignant and benign tissue based on their deoxy-hemoglobin content.